Par Pacific Hldgs (NYSE:PARR) reported quarterly sales of $2.11 billion which beat the analyst consensus estimate of $1.83 billion by 15.08 percent. This is a 72.91 percent increase over sales of $1.22 billion the same period last year.
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
